Another recent study uncovered that exosomal GP73 from tumor cells can enter vascular endothelial cells, competitively binding to the E3 ubiquitin ligase HECT domain containing 1 (HECTD1), preventing the ubiquitination of substrate protein growth factor receptor-bound protein 2 (GRB2) (22). This evidence concerns the gene GRB2 and neoplasm.